32 Participants Needed

Imaginal Exposure for Hoarding Disorder

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Imaginal Exposure Writing for Hoarding Disorder?

The research suggests that intrusive imagery plays a significant role in Hoarding Disorder, and imagery-based interventions could be beneficial. While specific data on Imaginal Exposure Writing is not provided, the potential of imagery-based interventions is highlighted, indicating that addressing intrusive imagery might help reduce hoarding symptoms.12345

How is Imaginal Exposure Writing treatment different from other treatments for hoarding disorder?

Imaginal Exposure Writing is unique because it focuses on addressing intrusive imagery (unwanted mental pictures) that people with hoarding disorder experience, especially when discarding items. This approach is different from other treatments as it directly targets the emotional and cognitive aspects of hoarding by helping individuals confront and process these distressing images.34678

What is the purpose of this trial?

The present study will test a potential new treatment strategy, imaginal exposure, for hoarding disorder. Although cognitive behavioral therapy often reduces hoarding, some people do not want to start, or cannot handle, that option. To help such individuals, the present study will provide imaginal exposure therapy to people with hoarding disorder, wherein they imagine discarding possessions as a way of becoming acclimated to the idea. We predict that imaginal exposure will improve hoarding symptoms as well as two psychological experiences linked to the condition: intolerance of uncertainty and emotional avoidance.

Research Team

KF

Katie Fracalanza, PhD

Principal Investigator

Stanford University

Eligibility Criteria

This trial is for English-speaking adults over 18 with hoarding disorder as their primary condition, regardless of gender or ethnicity. It's not suitable for those currently in cognitive behavioral therapy, suffering from severe depression, or at risk of suicide.

Inclusion Criteria

You are being treated for Hoarding Disorder as your main medical condition.
Willing and able to understand and complete consent and study procedures
My gender and ethnicity do not limit my participation.
See 1 more

Exclusion Criteria

You have thoughts of hurting or killing yourself and scored 4 or higher on the C-SSRS Suicidal Ideation Subscale.
I have been diagnosed with severe depression.
I am currently undergoing Cognitive Behavioral Therapy.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in imaginal exposure therapy, writing about worst-case scenarios regarding discarding possessions for 20 minutes on each of 3 consecutive days

1 week
3 visits (virtual)

Follow-up

Participants are monitored for changes in hoarding symptoms, intolerance of uncertainty, and emotional avoidance

1 week

Treatment Details

Interventions

  • Imaginal Exposure Writing
  • Neutral Writing
Trial Overview The study tests imaginal exposure therapy where participants imagine discarding items to reduce hoarding symptoms. This approach is compared to neutral writing and aims to ease the discomfort associated with throwing things away.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Imaginal Exposure WritingExperimental Treatment1 Intervention
People with hoarding disorder will write for 20 minutes on each of 3 consecutive days about their worst-case scenario regarding discarding a possession (i.e., imaginal exposure).
Group II: Neutral WritingPlacebo Group1 Intervention
People with hoarding disorder will write for 20 minutes on each of 3 consecutive days about what they would do if they had a day off work or school.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

Brain & Behavior Research Foundation

Collaborator

Trials
63
Recruited
2,900+

Findings from Research

A non-inferiority trial is being conducted to compare the effectiveness of group cognitive-behavioral therapy (CBT) and a structured support group called Buried in Treasures (BiT) for treating hoarding disorder, involving 300 participants over 16 weeks.
The primary goal of the study is to assess whether BiT can effectively reduce hoarding symptoms to a level comparable to that of traditional CBT, potentially increasing treatment accessibility for individuals with hoarding disorder.
Comparison of a peer facilitated support group to cognitive behavior therapy: Study protocol for a randomized controlled trial for hoarding disorder.Uhm, SY., Tsoh, JY., Mackin, RS., et al.[2022]

References

Comparison of a peer facilitated support group to cognitive behavior therapy: Study protocol for a randomized controlled trial for hoarding disorder. [2022]
A Standardized Approach to Calculating Clinically Significant Change in Hoarding Disorder Using the Saving Inventory-Revised. [2022]
Challenges and advances in treating hoarding. [2011]
The Role of Intrusive Imagery in Hoarding Disorder. [2020]
An intensive time-series evaluation of the effectiveness of cognitive behaviour therapy for hoarding disorder: a 2-year prospective study. [2019]
Acceptability of Treatments and Services for Individuals with Hoarding Behaviors. [2020]
Older adult hoarders' experiences of being helped by volunteers and volunteers' experiences of helping. [2022]
Experiential avoidance and emotion regulation difficulties in hoarding disorder. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security